The Effect of Internalized Stigma Management Program on Depressive Symptoms among Patient with Opioid use Disorder
Article Sidebar
Main Article Content
Abstract
Purpose: 1) To compare depressive symptoms of patients with opioid use disorder who received internalized stigma management program measured at pre-intervention, the end of the intervention, and at one-month post-intervention. 2) To compare depressive symptoms of patients with opioid use disorder who received internalized stigma management programs and those who received regular nursing care.
Design: Quasi-experimental research
Methods: Thirty-eight opioid use disorder patients who have depressive symptoms and received services at the Methadone Clinic in Princess Mother National Institute on Drug Abuse Treatment were enrolled. Questionnaires were composed of Internalized stigma management program, Demographic data, The 9 Questions Depression Rating Scale revised for Thai Central Dialect, and The brief opioid stigma scale. The questionnaires were tested for content validities and the reliabilities were .77 and .79, respectively. Data were analyzed using descriptive statistics, repeated measure ANOVA and Least Significant Difference.
Findings: 1) The depressive symptoms in the experimental group compared between pre-post and one-month post-intervention are not significant. 2) The depressive symptoms among patients with opioid use disorder in the experimental group at post-intervention and one-month post-intervention were significantly better than the control group.
Conclusion: This program can be used for reduced depressive symptoms among patients with opioid use disorder in a short time.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์ของบทความที่ตีพิมพ์เป็นของวารสารพยาบาลศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย ทั้งฉบับตีพิมพ์เป็นรูปเล่มและเอกสารออนไลน์
References
United Nations Office on Drugs and Crime.
Analysis of drug markets: Opiates,
cocaine, cannabis, synthetic drugs.
Austria: United Nations; 2018.
Degenhardt L, Peacock A, Colledge S, Leung
J, Grebely J, Vickerman P, et al. Global
prevalence of injecting drug use and
sociodemographic characteristics and
prevalence of HIV, HBV, and HCV in
people who inject drugs: a multistage
systematic review. Lancet Glob Health
; 5(12): e1192-e207.
Heimer R, Barbour R, Palacios WR, Nichols LG,
Grau LE. Associations between injection
risk and community disadvantage
among suburban injection drug users in
southwestern Connecticut, USA. AIDS
Behav 2014; 18(3): 452-63.
Armstrong G, Nuken A, Samson L, Singh S,
Jorm AF, Kermode M. Quality of life,
depression, anxiety and suicidal ideation
among men who inject drugs in Delhi,
India. BMC Psychiatry 2013; 13(151):
-35.
Williams SC, Davey-Rothwell MA, Tobin KE,
Latkin CA. People who inject drugs and
have mood disorders–a brief assessment
of health risk behaviors. Subst 2017;
(9): 1175-84.
Li L, Tuan NA, Liang L-J, Lin C, Farmer SC,
Flore M. Mental health and family
relations among people who inject
drugs and their family members in
Vietnam. Int J Drug Policy 2013; 24(6):
-9.
Yang LH, Grivel MM, Anderson B, Bailey GL,
Opler M, Wong LY, et al. A new brief
opioid stigma scale to assess perceived
public attitudes and internalized stigma:
Evidence for construct validity. J Subst
Abuse Treat 2019; 99: 44-51.
Luoma JB, Kohlenberg BS, Hayes SC,
Bunting K, Rye AK. Reducing self-stigma
in substance abuse through acceptance
and commitment therapy: Model,
manual development, and pilot
outcomes. Addict Res Theory 2008;
(2): 149-65.
Smith LR, Earnshaw VA, Copenhaver MM,
Cunningham CO. Substance Use Stigma:
Reliability and validity of a theory-based
scale for substance-using populations.
Drug Alcohol Depend 2016; 162: 34-43.
Hayes SC, Luoma JB, Bond FW, Masuda A,
Lillis J. Acceptance and Commitment
Therapy: Model, processes and
outcomes. Behav Res Ther 2006; 44(1):
-25.
Haenjohn J. Acceptance and commitment
therapy. Chonburi: get good creation
company limited; 2018.
Yalom ID. The theory and practice of group
psychotherapy. 4th ed. New York: Basic
Books; 1995.
Kongsuk T, Arunpongpaisal S, Janthong S,
Prukkanone B, Sukhawaha S,
Leejongpermpoon J. Criterion-related
validity of the 9 questions depression
rating scale revised for Thai Central
Dialect. J Psychiatr Assoc Thailand 2018;
(4): 321-34. (in Thai)
Saedy M, Kooshki S, Firouzabadi MJ,
Emamipour S, Ardani AR. Effectiveness
of acceptance-commitment therapy on
anxiety and depression among patients
on methadone treatment: A Pilot Study.
Iran J Psychiatry Behav Sci 2015; 9(1):
e222. Doi: 10.17795/ijpbs222
Bohlmeijer ET, Fledderus M, Rokx TAJJ,
Pieterse ME. Efficacy of an early
intervention based on acceptance and
commitment therapy for adults with
depressive symptomatology: Evaluation
in a randomized controlled trial. Behav
Res Ther 2011; 49(1): 62-7.
Hiller SP, Syvertsen JL, Lozada R, Ojeda VD.
Social support and recovery among
Mexican female sex workers who inject
drugs. J Subst Abuse Treat 2013; 45(1):
-54.
Li J, Gu J, Lau JTF, Chen H, Mo PKH, Tang
M. Prevalence of depressive symptoms
and associated factors among people
who inject drugs in China. Drug Alcohol
Depend 2015; 151: 228-35.